Evaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma.
Niitsu, N
Evaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma. [electronic resource] - Acta haematologica 1996 - 36-40 p. digital
Publication Type: Journal Article
0001-5792
10.1159/000203712 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carboplatin--administration & dosage
Cytarabine--administration & dosage
Drug Evaluation
Etoposide--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Recurrence
Remission Induction
Time Factors
Evaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma. [electronic resource] - Acta haematologica 1996 - 36-40 p. digital
Publication Type: Journal Article
0001-5792
10.1159/000203712 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carboplatin--administration & dosage
Cytarabine--administration & dosage
Drug Evaluation
Etoposide--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Recurrence
Remission Induction
Time Factors